“Biorevolution” in society to drive Bayer business

摘要

Bayer’s Crop Science division expects 2021 to be the start of a new growth phase for the business as it benefits from “megatrends” in the society. Bayer Group chief executive oicer Werner Baumann told the virtual Capital Markets Day 2021 this week that the Crop Science business and the wider group was in an “excellent position” to benefit from a “biorevolution” in health and nutrition.